Testing effectiveness (Phase 2)Study completedNCT01305135
What this trial is testing
Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes
Who this might be right for
High Grade Myelodysplastic Syndrome Lesions
Groupe Francophone des Myelodysplasies 41